Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Sell

C

Lixte Biotechnology Holdings, Inc. Common Stock (LIXT)

Pharmaceutical Preparations

https://www.lixte.com

Lixte Biotechnology Holdings Inc is a drug discovery company that has a developed unique, proprietary, first-in-class protein phosphatase inhibitor, LB-100, as its lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in combination with standard anti-cancer therapies, including cytotoxic drugs, radiation, and immune checkpoint blockers. The Company's product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and x-ray and immune checkpoint blockers.

248 ROUTE 25A, NO. 2
EAST SETAUKET, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/05/2007

Market Cap

4,588,552

Shares Outstanding

2,250,000

Weighted SO

2,249,290

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ALLR --.--%

NRBO --.--%

HILS --.--%

VRAX --.--%

QNRX --.--%

INDP --.--%

KTTA --.--%

KRBP --.--%

BDRX --.--%

Beta

-0.2160

Last Div

0.0000

Range

1.58-4.42

Chg

0.0600

Avg Vol

32211

Mkt Cap

4588552

Exch

NASDAQ

Country

US

Phone

631 830 7092

DCF Diff

-0.1641

DCF

2.1941

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.4951

P/FV

2.0429

Div Yield %

0.0000

P/E

-1.1377

PEG

-0.0122

Payout

0.0000

Current Ratio

6.3294

Quick Ratio

6.3294

Cash Ratio

6.1576

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.2402

ROA

-1.5119

ROE

-1.1290

ROCE

-1.7925

NI/EBT

1.0000

EBT/EBIT

1.0018

EBIT/Rev

0.0000

Debt Ratio

-0.1580

D/E

-0.1876

LT Debt/Cap

0.0000

Total Debt/Cap

-0.2310

Int Coverage

-312.1516

CF/Debt

8.1971

Equity Multi

1.1876

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.5359

FCF/Share

-1.5359

Cash/Share

1.1538

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

8.1971

ST Coverage

8.1971

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

2.0429

P/B

2.0429

P/S

0.0000

P/E

-1.1377

P/FCF

-1.3282

P/OCF

-1.3282

P/CF

-1.3282

PEG

-0.0122

P/S

0.0000

EV Multiple

-0.4951

P/FV

2.0429

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation